Literature DB >> 9261400

A novel type of defective viral genome suggests a unique strategy to establish and maintain persistent lymphocytic choriomeningitis virus infections.

B J Meyer1, P J Southern.   

Abstract

Defective interfering RNAs have long been thought to be a causal factor of persistent RNA virus infections. Here we describe a novel type of defective genome of lymphocytic choriomeningitis virus and the unique mechanism by which these RNAs appear to contribute to the establishment and maintenance of persistent infection. The defective genomes have short deletions in the untranslated regions at their termini and additional nontemplated terminal nucleotides. This and previous work from our laboratory suggested that the RNAs were competent for replication but not for transcription. From experiments using a technique to unambiguously determine the sequences of individual RNA termini, it appears that some truncated RNAs can be repaired. The data suggest that the loss or gain of nucleotides from the RNA termini during the course of infection is the mechanism for establishing and maintaining persistence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261400      PMCID: PMC191956     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

Review 1.  DNA-joining enzymes: a review.

Authors:  N P Higgins; N R Cozzarelli
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

2.  Homologous interference of lymphocytic choriomeningitis virus: detection and measurement of interference focus-forming units.

Authors:  M Popescu; H Schaefer; F Lehmann-Grube
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

3.  Prevention of virus-induced cerebellar diseases by defective-interfering lymphocytic choriomeningitis virus.

Authors:  R M Welsh; P W Lampert; M B Oldstone
Journal:  J Infect Dis       Date:  1977-09       Impact factor: 5.226

Review 4.  Structural components and replication of arenaviruses.

Authors:  I R Pedersen
Journal:  Adv Virus Res       Date:  1979       Impact factor: 9.937

5.  Defective viral particles and viral disease processes.

Authors:  A S Huang; D Baltimore
Journal:  Nature       Date:  1970-04-25       Impact factor: 49.962

Review 6.  The virology and immunobiology of lymphocytic choriomeningitis virus infection.

Authors:  M J Buchmeier; R M Welsh; F J Dutko; M B Oldstone
Journal:  Adv Immunol       Date:  1980       Impact factor: 3.543

7.  3'-terminal labelling of RNA with T4 RNA ligase.

Authors:  T E England; O C Uhlenbeck
Journal:  Nature       Date:  1978-10-12       Impact factor: 49.962

8.  The 5' nontranslated region of potato virus X RNA affects both genomic and subgenomic RNA synthesis.

Authors:  K H Kim; C Hemenway
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Inhibition of immunologic injury of cultured cells infected with lymphocytic choriomeningitis virus: role of defective interfering virus in regulating viral antigenic expression.

Authors:  R M Welsh; M B Oldstone
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

View more
  22 in total

1.  NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs.

Authors:  K J Lee; I S Novella; M N Teng; M B Oldstone; J C de La Torre
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Accumulation of terminally deleted RNAs may play a role in Seoul virus persistence.

Authors:  B J Meyer; C Schmaljohn
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus.

Authors:  Mar Perez; Juan Carlos de la Torre
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  Replicon system for Lassa virus.

Authors:  Meike Hass; Uta Gölnitz; Stefanie Müller; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  Genomic and biological characterization of aggressive and docile strains of lymphocytic choriomeningitis virus rescued from a plasmid-based reverse-genetics system.

Authors:  Minjie Chen; Shuiyun Lan; Rong Ou; Graeme E Price; Hong Jiang; Juan Carlos de la Torre; Demetrius Moskophidis
Journal:  J Gen Virol       Date:  2008-06       Impact factor: 3.891

Review 6.  Within host RNA virus persistence: mechanisms and consequences.

Authors:  Richard E Randall; Diane E Griffin
Journal:  Curr Opin Virol       Date:  2017-03-17       Impact factor: 7.090

7.  Functional characterization of the genomic promoter of borna disease virus (BDV): implications of 3'-terminal sequence heterogeneity for BDV persistence.

Authors:  Debralee Rosario; Mar Perez; Juan Carlos de la Torre
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  Viral persistence and chronic immunopathology in the adult central nervous system following Coxsackievirus infection during the neonatal period.

Authors:  Ralph Feuer; Chelsea M Ruller; Naili An; Jenna M Tabor-Godwin; Ross E Rhoades; Sonia Maciejewski; Robb R Pagarigan; Christopher T Cornell; Stephen J Crocker; William B Kiosses; Ngan Pham-Mitchell; Iain L Campbell; J Lindsay Whitton
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

9.  Molecular characterization of the genes coding for glycoprotein and L protein of lymphocytic choriomeningitis virus strain MX.

Authors:  Jana Tomaskova; Martina Labudova; Juraj Kopacek; Silvia Pastorekova; Jaromir Pastorek
Journal:  Virus Genes       Date:  2008-05-21       Impact factor: 2.332

10.  Visualization of Arenavirus RNA Species in Individual Cells by Single-Molecule Fluorescence In Situ Hybridization Suggests a Model of Cyclical Infection and Clearance during Persistence.

Authors:  Benjamin R King; Aubin Samacoits; Philip L Eisenhauer; Christopher M Ziegler; Emily A Bruce; Daniel Zenklusen; Christophe Zimmer; Florian Mueller; Jason Botten
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.